Inherited gene changes in blood cancers with family history
Part of Blood & lymphatic, Cancer clinical trials.
This study looks for inherited gene changes in people with myeloproliferative neoplasms (MPNs) who have a family history of similar blood disorders. If you qualify, it may help explain why some families have higher risk and could guide future screening.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a confirmed diagnosis of essential thrombocythemia, polycythemia vera, or myelofibrosis.
- You must have at least one close relative (parent, sibling, child, grandparent, or grandchild) with a similar blood disorder.
- You must not have any other blood-related diagnoses.
- You must be willing to sign a consent form to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a “registry,” meaning it collects information about adults with specific types of myeloproliferative neoplasms (MPNs). It helps researchers better understand these diseases and may improve future care.
This study looks at immune cells (monocytes) in people with certain blood cancers. Researchers want to understand how these cells behave and change over time. You can join if you are newly diagnosed and haven't started treatment yet.
This study explores whether certain inherited gene changes make people more likely to develop myeloproliferative neoplasms (MPNs). It is looking at patients who were diagnosed at a young age or have a family history of blood cancers, to better understand the genetic causes of these conditions.
This study looks at gene patterns in people with blood cancers to better understand the disease and find possible treatments. If you are being tested for a blood cancer or have a blood cancer that came back or got worse, you may be able to join.
This study uses advanced DNA testing to look for inherited gene changes in people with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). It may help explain whether your illness could be part of a family-linked risk syndrome, which can guide treatment and family planning.
This study offers genetic testing to people newly diagnosed with a blood cancer. It looks for inherited gene changes that might affect your cancer or your family's health.
Hear when a new Polycythemia Vera trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.